S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Miragen TherapeuticsPotNetworkBioceptAvant DiagnosticsOpGen
SymbolNASDAQ:MGENOTCMKTS:POTNNASDAQ:BIOCOTCMKTS:AVDXNASDAQ:OPGN
Price Information
Current Price$0.65$0.02$0.28$0.03$1.68
52 Week RangeBuyN/ABuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/ABuy
Consensus Price Target$6.50N/A$1.00N/A$7.93
% Upside from Price Target905.10% upsideN/A257.14% upsideN/A372.22% upside
Trade Information
Market Cap$24.42 million$16.52 million$14.40 million$10.78 million$8.35 million
Beta1.032.981.529.420.56
Average Volume4,543,7741,031,8532,883,3924,9361,456,402
Sales & Book Value
Annual Revenue$8.39 millionN/A$3.25 million$250,000.00$2.95 million
Price / Sales2.45N/A4.1043.133.19
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.66 per shareN/A$0.66 per share$0.01 per share$7.66 per share
Price / Book0.39N/A0.423.200.22
Profitability
Net Income$-32,700,000.00N/A$-24,570,000.00$-2,370,000.00$-13,370,000.00
EPS($1.10)N/AN/AN/A($44.40)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E RatioN/A∞∞∞N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,037.02%N/A-552.54%N/A-397.44%
Return on Equity (ROE)-113.02%N/A-268.76%-143.01%-662.90%
Return on Assets (ROA)-80.64%N/A-156.38%-51.41%-144.19%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.23%N/A0.13%N/A1.07%
Current Ratio3.68%N/A1.83%0.02%0.31%
Quick Ratio3.68%N/A1.71%0.02%0.24%
Ownership Information
Institutional Ownership Percentage28.42%0.01%2.16%0.03%5.40%
Insider Ownership Percentage5.30%4.20%0.32%38.01%4.96%
Miscellaneous
Employees771395244
Shares Outstanding31.79 million727.84 million47.62 million336.96 million5.60 million
Next Earnings Date3/11/2020 (Confirmed)N/A3/26/2020 (Estimated)N/A3/2/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel